Free cookie consent management tool by TermsFeed Generator Update cookies preferences
 
HomeCategory

Company News - NewScen Coast Biotech

HIV Rapid Test: Separate HIV-1 & HIV-2 Detection | IVDR Class D

Separate HIV-1 and HIV-2 Detection with Dedicated Result Lines in 15 Minutes: Why an IVDR-Class-D Rapid Test Belongs in Every Screening Portfolio Early HIV detection saves lives. The sooner a person knows their status, the sooner they can access life-saving antiretroviral therapy, reduce viral load to undetectable levels, and prevent onward transmission. For healthcare systems...

NEWSCEN IVD Solutions | IVDR & CE-Marked Self-Tests

NEWSCEN IVD Solutions bring together infectious disease diagnostics, clinical health testing and reproductive health self-testing for the European and international markets. Our portfolio includes an IVDR HIV test, HCV testing moving toward IVDR certification, and CE-marked IVDD self-tests for SF, FOB, LH, FSH and HCG. NEWSCEN IVD Solutions for a Changing European Diagnostic Market The...

FOB Test Kit: A Reliable Rapid Solution for Fecal Occult Blood Detection

Introduction Gastrointestinal (GI) bleeding can occur without obvious symptoms, making reliable detection methods important for early clinical evaluation and health management. NewScen One-Step Fecal Occult Blood (FOB) Diagnostic Kit provides a convenient and reliable solution for detecting human hemoglobin (Hb) in fecal samples. Based on advanced immunochromatographic technology, the test offers rapid results, simple operation,...

World Hepatitis Day 2026: Every Test Brings Us One Step Closer to Elimination

Every year on July 28, the world observes World Hepatitis Day, one of the World Health Organization’s official global health campaigns. The day unites governments, healthcare providers, laboratories, and diagnostic manufacturers in raising awareness about viral hepatitis and promoting early testing. Although hepatitis is preventable, treatable, and in many cases curable, millions of people continue...

NewScen COVID-19 Antigen Microfluidic Chip, COVID-19 Antigen Microfluidic Triple Test & COVID-19 Antigen Microfluidic Combo Test have been certified by China “Export White List”

By  03:22 a.m., Jan. 27, 2021, Beijing time, the number of diagnosed and confirmed COVID-19 cases has exceeded 100 million globally! As the most phenomenal and severe infectious disease known to the world in the past 100 years, the COVID-19 pandemic is rare in human history in terms of its wide range of influence, the accumulated number of...